Publications by authors named "A Manzaneque"

Claim this Profile
C
Cost-effectiveness of adjuvant atezolizumab versus best supportive care in the treatment of patients with resectable early-stage non-small cell lung cancer and overexpression of PD-L1.
Vicente Escudero-Vilaplana, Roberto Collado-Borrell, Javier De Castro, Amelia Insa, Alex Martínez, Alba Manzaneque

J Med Econ· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic burden of locoregional and metastatic relapses in resectable early-stage non-small cell lung cancer in Spain.
Javier De Castro, Amelia Insa, Roberto Collado-Borrell, Vicente Escudero-Vilaplana, Alex Martínez, Alba Manzaneque

BMC Pulm Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retreatment with full-dose cytarabine in a patient with previous neurological toxicity.
Núria Meca Casasnovas, Alba Manzaneque, Ana Muntañola, Genís Castells

J Oncol Pharm Pract· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use and safety of denosumab in cancer patients.
Alba Manzaneque, Cristian Chaguaceda, Mireia Mensa, Carla Bastida, Natàlia Creus-Baró

Int J Clin Pharm· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potentially Inappropriate Prescription in Patients With a History of Allergy to β-Lactam Antibiotics: A Health Care Challenge.
A Manzaneque, C López-Cabezas, M Mensa, A García-Moral, J Sánchez-López

J Investig Allergol Clin Immunol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis